The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells

INTRODUCTION: Tamoxifen is an anti-estrogen drug used in treatment of Estrogen Receptor (ER) positive breast cancer. Effects and side effects of tamoxifen is the sum of tamoxifen and all its metabolites. 4-Hydroxytamoxifen (4OHtam) and 4-hydroxy-N-demethyltamoxifen (4OHNDtam, endoxifen) both have ER...

Descripción completa

Detalles Bibliográficos
Autores principales: Helland, Thomas, Gjerde, Jennifer, Dankel, Simon, Fenne, Ingvild S., Skartveit, Linn, Drangevåg, Andreas, Bozickovic, Olivera, Flågeng, Marianne Hauglid, Søiland, Håvard, Mellgren, Gunnar, Lien, Ernst A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395096/
https://www.ncbi.nlm.nih.gov/pubmed/25867603
http://dx.doi.org/10.1371/journal.pone.0122339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395096/
https://www.ncbi.nlm.nih.gov/pubmed/25867603
http://dx.doi.org/10.1371/journal.pone.0122339

Ejemplares similares